Tech Session I: Nanomedicine and Nanoscale Delivery (Focus: Gene)

Chair(s)

• 

  Simon Drescher, PD Dr (he/him/his)

  Managing Director
  Phospholipid Research Center
  Heidelberg, Baden-Wurttemberg, Germany

Co-Chair(s)

• 

  Cristina Fornaguera Puigvert, PhD (she/her/hers)

  Associate professor and group leader
  Institut Químic de Sarrià (IQS) - Universitat Ramon Llull (URL)
  Barcelona, Catalonia, Spain

Development, physicochemical and biological characterization, in vivo validation, delivery of therapeutics, functionalization with active-targeting moieties, long-acting formulations, controlled release, injectables, implantables. (Focus: Gene)

Presentations:

• 10:04 AM - 10:29 AM EDT

  Characterizing CRISPR-Cas ribonucleoprotein delivery with bioreducible polymer nanoparticles
  

  Invited Speaker - Exceptional Abstract: Christopher L. Grigsby, PhD (he/him/his) – Queen's University Belfast
• 10:29 AM - 10:54 AM EDT

  Gold Nanoparticles as Carriers of MicroRNA Mimics for Cancer Immunotherapy and Muscular Diseases
  

  Invited Speaker - Exceptional Abstract: Álvaro Somoza, PhD (he/him/his) – IMDEA Nanociencia
• 10:54 AM - 11:05 AM EDT

  Overcoming Chemoresistance in Colorectal Cancer by FcRn-Driven Nucleic Acid Delivery
  

  Oral Abstract Speaker: Natália Teixeira, MSc – Instituto de Investigação e Inovação em Saúde (i3S)
• 11:05 AM - 11:16 AM EDT

  Hybrid LNP prime dendritic cells for nucleotide delivery
  

  Oral Abstract Speaker: Riddha Das, PhD (she/her/hers) – Center for Systems Biology, Massachusetts General Hospital
• 11:16 AM - 11:27 AM EDT

  Tunable surface charge on polymer nanoparticles and the effect on endothelial cellular drug delivery
  

  Oral Abstract Speaker: Jianlei Wu, MS (he/him/his) – Villanova University
• 11:27 AM - 11:38 AM EDT

  Targeted-LNPs capable of functional DNA delivery to T cells enable in vivo CAR-T generation
  

  Oral Abstract Speaker: Daniel Murphy, PhD – Nanocell Therapeutics
• 11:38 AM - 11:49 AM EDT

  Pulmonary delivery of circular RNA therapeutics for cystic fibrosis
  

  Oral Abstract Speaker: Ri Tang, MD (he/him/his) – University of Michigan
• 11:49 AM - 12:00 PM EDT

  Towards vascularized bone tissue engineering: siRNA Delivery via Cross-Linked Gelatin Microparticles
  

  Oral Abstract Speaker: Franziska Mitrach, PhD (she/her/hers) – Medical Faculty, University of Leipzig